Mullan; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mullan; Michael.The latest application filed is for "amino acid derivatives for the treatment of inflammatory diseases".

Company Profile

1.2.14

Mullan; Michael - Sarasota FL
Mullan; Michael - Tampa FL
Mullan, Michael - Bradenton FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Amino Acid Derivatives for the Treatment of Inflammatory Diseases App 20220081415 - Jin; Chao ; et al.	2022-03-17
Pharmaceutical Composition App 20210052559 - Kompothecras; Gary ; et al.	2021-02-25
Method of Treating Inflammatory Lung Disease App 20160030407 - Mullan; Michael ; et al.	2016-02-04
Inhibition of angiogenesis by A-.beta. peptides Grant 7,589,168 - Paris , et al. September 15, 2	2009-09-15
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of Alzheimer's disease App 20070160615 - Tan; Jun ; et al.	2007-07-12
Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors App 20040229816 - Paris, Daniel ; et al.	2004-11-18
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology Grant 6,787,318 - Tan , et al. September 7, 2	2004-09-07
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease App 20040146949 - Tan, Jun ; et al.	2004-07-29
Method and assay for diagnosing substance dependency App 20040048238 - Town, Terence C. ; et al.	2004-03-11
Methods of identifying compounds useful in the inhibition of neurodegenerative disease App 20030077573 - Paris, Daniel ; et al.	2003-04-24
Modulation of angiogenesis by A-beta peptides App 20030077261 - Paris, Daniel ; et al.	2003-04-24
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease App 20030077667 - Tan, Jun ; et al.	2003-04-24
CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker in alzheimer's disease App 20020137108 - Mullan, Michael ; et al.	2002-09-26
Methods and compositions for stimulating CD 45 and thereby suppressing microglial activation associated with Alzheimer's disease App 20020102259 - Tan, Jun ; et al.	2002-08-01
Methods and assays for diagnosing alzheimer's disease App 20020025527 - Crawford, Fiona ; et al.	2002-02-28
Method and assay for diagnosing substance dependency App 20020006624 - Town, Terence C. ; et al.	2002-01-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.